Black Rock Inc. Fibrogen Inc Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Fibrogen Inc stock. As of the latest transaction made, Black Rock Inc. holds 2,409,650 shares of FGEN stock, worth $20.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,409,650
Previous 6,967,918
65.42%
Holding current value
$20.9 Million
Previous $16.4 Million
86.91%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding FGEN
# of Institutions
8Shares Held
3.98MCall Options Held
35KPut Options Held
0-
Pictet Asset Management Sa Geneva 73, V81.37MShares$11.9 Million0.0% of portfolio
-
Intercontinental Wealth Advisors, LLC95.7KShares$831,1980.06% of portfolio
-
Eaton Vance Management Boston, MA94.5KShares$821,0130.0% of portfolio
-
Cibc Private Wealth Group, LLC7.18KShares$62,3590.0% of portfolio
-
Cutler Group LP900Shares$7,8210.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $815M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...